XML 18 R9.htm IDEA: XBRL DOCUMENT
v3.23.1

Shareholders' Equity | 6 Months Ended
--- | ---
Mar. 31, 2023
Stockholders' Equity Note [Abstract] |
Shareholders' Equity | Shareholders' Equity Changes in certain components of shareholders' equity for the first two quarters of fiscal years 2023 and 2022 were as follows:
| Common Stock Issued at Par Value |  | Capital in Excess of Par Value |  | Retained Earnings |  | Deferred Compensation |  | Treasury Stock
(Millions of dollars) | Shares (in thousands) |  | Amount
Balance at September 30, 2022 | $ | 365 |  |  | $ | 19,553 |  |  | $ | 15,157 |  |  | $ | 23 |  |  | (81,283) |  |  | $ | (8,330) |
Net income | — |  |  | — |  |  | 509 |  |  | — |  |  | — |  |  | — |
Common dividends ($0.91 per share) | — |  |  | — |  |  | (259) |  |  | — |  |  | — |  |  | — |
Preferred dividends | — |  |  | — |  |  | (23) |  |  | — |  |  | — |  |  | — |
Issuance of shares under employee and other plans, net | — |  |  | (52) |  |  | — |  |  | — |  |  | 556 |  |  | (3) |
Share-based compensation | — |  |  | 89 |  |  | — |  |  | — |  |  | — |  |  | — |
Common stock held in trusts, net (a) | — |  |  | — |  |  | — |  |  | — |  |  | (11) |  |  | — |
Balance at December 31, 2022 | $ | 365 |  |  | $ | 19,590 |  |  | $ | 15,384 |  |  | $ | 24 |  |  | (80,738) |  |  | $ | (8,333) |
Net income | — |  |  | — |  |  | 460 |  |  | — |  |  | — |  |  | — |
Common dividends ($0.91 per share) | — |  |  | — |  |  | (259) |  |  | — |  |  | — |  |  | — |
Preferred dividends | — |  |  | — |  |  | (23) |  |  | — |  |  | — |  |  | — |
Issuance of shares under employee and other plans, net | — |  |  | (7) |  |  | — |  |  | — |  |  | 21 |  |  | 5 |
Share-based compensation | — |  |  | 56 |  |  | — |  |  | — |  |  | — |  |  | — |
Common stock held in trusts, net (a) | — |  |  | — |  |  | — |  |  | — |  |  | 92 |  |  | — |
Balance at March 31, 2023 | $ | 365 |  |  | $ | 19,639 |  |  | $ | 15,563 |  |  | $ | 24 |  |  | (80,625) |  |  | $ | (8,327) |
| Common Stock Issued at Par Value |  | Capital in Excess of Par Value |  | Retained Earnings |  | Deferred Compensation |  | Treasury Stock
(Millions of dollars) | Shares (in thousands) |  | Amount
Balance at September 30, 2021 | $ | 365 |  |  | $ | 19,272 |  |  | $ | 13,826 |  |  | $ | 23 |  |  | (80,164) |  |  | $ | (7,723) |
Net income | — |  |  | — |  |  | 677 |  |  | — |  |  | — |  |  | — |
Common dividends ($0.87 per share) | — |  |  | — |  |  | (248) |  |  | — |  |  | — |  |  | — |
Preferred dividends | — |  |  | — |  |  | (23) |  |  | — |  |  | — |  |  | — |
Issuance of shares under employee and other plans, net | — |  |  | (71) |  |  | — |  |  | — |  |  | 762 |  |  | 19 |
Share-based compensation | — |  |  | 83 |  |  | — |  |  | — |  |  |  |  | — |
Common stock held in trusts, net (a) | — |  |  | — |  |  | — |  |  | — |  |  | (5) |  |  | — |
Repurchase of common stock (b) | — |  |  | 150 |  |  | — |  |  | — |  |  | (462) |  |  | (150) |
Balance at December 31, 2021 | $ | 365 |  |  | $ | 19,435 |  |  | $ | 14,233 |  |  | $ | 24 |  |  | (79,869) |  |  | $ | (7,855) |
Net income | — |  |  | — |  |  | 454 |  |  | — |  |  | — |  |  | — |
Common dividends ($0.87 per share) | — |  |  | — |  |  | (248) |  |  | — |  |  | — |  |  | — |
Preferred dividends | — |  |  | — |  |  | (23) |  |  | — |  |  | — |  |  | — |
Issuance of shares under employee and other plans, net | — |  |  | (21) |  |  | — |  |  | 1 |  |  | 284 |  |  | 14 |
Share-based compensation | — |  |  | 56 |  |  | — |  |  | — |  |  | — |  |  | — |
Common stock held in trusts, net (a) | — |  |  | 24 |  |  | — |  |  | — |  |  | 9 |  |  | (24) |
Balance at March 31, 2022 | $ | 365 |  |  | $ | 19,495 |  |  | $ | 14,416 |  |  | $ | 24 |  |  | (79,575) |  |  | $ | (7,866) |
(a)Common stock held in trusts consists of the Company’s shares held in rabbi trusts in connection with deferred compensation under the Company’s employee salary and bonus deferral plan and directors’ deferral plan. During the second quarter of fiscal year 2022, the common stock held in trusts was temporarily replaced with the Company’s Series C preferred shares to adhere to trust requirements until the Company’s spin-off of its Diabetes Care business was completed on April 1, 2022. (b)Represents shares received upon final settlement of an accelerated share repurchase agreement, and the related forward sale contract, entered into during the fourth quarter of fiscal year 2021. T he share repurchases were made pursuant to the repurchase program authorized by the Board of Directors on September 24, 2013 for 10 million shares, which has been fully utilized. In November 2021, the Board of Directors authorized the Company to repurchase up to an additional 10 million shares of BD common stock, for which there is also no expiration date. The components and changes of Accumulated other comprehensive income (loss) for the first two quarters of fiscal years 2023 and 2022 were as follows:
(Millions of dollars) | Total |  | Foreign Currency Translation |  | Benefit Plans |  | Cash Flow Hedges
Balance at September 30, 2022 | $ | (1,488) |  |  | $ | (987) |  |  | $ | (574) |  |  | $ | 75 |
Other comprehensive loss before reclassifications, net of taxes | (84) |  |  | (80) |  |  | — |  |  | (4) |
Amounts reclassified into income, net of taxes | 12 |  |  | — |  |  | 11 |  |  | 1 |
Balance at December 31, 2022 | $ | (1,559) |  |  | $ | (1,067) |  |  | $ | (563) |  |  | $ | 73 |
Other comprehensive loss before reclassifications, net of taxes | (29) |  |  | (21) |  |  | — |  |  | (8) |
Amounts reclassified into income, net of taxes | 13 |  |  | — |  |  | 11 |  |  | 2 |
Balance at March 31, 2023 | $ | (1,575) |  |  | $ | (1,088) |  |  | $ | (552) |  |  | $ | 67 |
(Millions of dollars) | Total |  | Foreign Currency Translation |  | Benefit Plans |  | Cash Flow Hedges
Balance at September 30, 2021 | $ | (2,088) |  |  | $ | (1,292) |  |  | $ | (784) |  |  | $ | (10) |
Other comprehensive income (loss) before reclassifications, net of taxes | 34 |  |  | 41 |  |  | — |  |  | (7) |
Amounts reclassified into income, net of taxes | 11 |  |  | — |  |  | 11 |  |  | — |
Balance at December 31, 2021 | $ | (2,043) |  |  | $ | (1,251) |  |  | $ | (774) |  |  | $ | (17) |
Other comprehensive income before reclassifications, net of taxes | 122 |  |  | 78 |  |  | — |  |  | 44 |
Amounts reclassified into income, net of taxes | 11 |  |  | — |  |  | 11 |  |  | — |
Balance at March 31, 2022 | $ | (1,910) |  |  | $ | (1,173) |  |  | $ | (763) |  |  | $ | 28 |
The amounts of foreign currency translation recognized in other comprehensive income during the three and six months ended March 31, 2023 and 2022 included net (losses) gains relating to net investment hedges. The amounts recognized in other comprehensive income relating to cash flow hedges during the three and six months ended March 31, 2023 and 2022 are primarily related to forward starting interest rate swaps. Additional disclosures regarding amounts the Company recognized in other comprehensive income relating to cash flow hedges during the three and six months ended March 31, 2023 and 2022 are provided in Note 11. The tax impacts for amounts recognized in other comprehensive income (loss) before reclassifications and for reclassifications out of Accumulated other comprehensive income (loss) relating to benefit plans and cash flow hedges during the three and six months ended March 31, 2023 and 2022 were immaterial to the Company's consolidated financial results.

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI https://asc.fasb.org/topic&trid=2208762 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 14 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 14 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 18 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (g) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 18 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (h) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 14 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 18 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 16 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (i) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 40 -Section 50 -Paragraph 6 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration